Key points are not available for this paper at this time.
Abstract Background Up to 10% of children are reported to be allergic to penicillin, but many allergy labels are unverified and may require formal testing. Inaccurate drug allergy labels are associated with a range of adverse clinical outcomes. Patients with hematological disorders may experience frequent and severe infections; those who have been incorrectly labeled penicillin allergic may benefit from allergy de‐labeling (ADL) efforts to facilitate access to beta‐lactam antibiotics. We developed a multidisciplinary, pharmacist‐driven process that enabled non‐allergist trained providers to assess and de‐label penicillin allergies in a pediatric hematology center. Methods Volunteers, including physicians, advanced practice providers, nurses, and pharmacists, were trained in skin testing and oral challenge procedures. Patients were identified by review of electronic medical records for penicillin or penicillin‐derivative allergy. Patient and family interviews were conducted in cases where a true penicillin allergy was deemed uncertain based on chart review. If allergy could not be de‐labeled by chart review or interview alone, patients were offered skin and/or oral challenge testing. Results Fifty‐nine patients were initially labeled as penicillin allergic. Allergy labels of 11 (19%) were removed by chart review only, and 15 (25%) after conducting interviews. A total of two (3%) patients were ineligible due to contraindications, and five (9%) declined participation. Twenty‐six patients (44%) underwent allergy testing (50% skin testing, 50% oral challenge) of which 23 (88%) were negative. Conclusions ADL was possible in most patients previously identified as penicillin allergic. Testing was well tolerated with no serious adverse effects.
Barker et al. (Sun,) studied this question.